Oncologists report high career satisfaction

February 6, 2014
Oncologists report high career satisfaction
Oncologists are overall very satisfied with their careers, according to a study published online Jan. 27 in the Journal of Clinical Oncology.

(HealthDay)—Oncologists are overall very satisfied with their careers, according to a study published online Jan. 27 in the Journal of Clinical Oncology.

Tait D. Shanafelt, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues surveyed U.S. oncologists (1,117 completed full length surveys; 49.6 percent women) to evaluate burnout and career satisfaction at all career stages.

The researchers found that 33.8 percent of the respondents were in academic practice (AP) and 43.2 percent were in private practice (PP). On average, oncologists worked 57.6 hours per week (AP, 58.6 hours per week; PP, 62.9 hours per week) and saw a mean of 52 outpatients per week. Based on the emotional exhaustion and/or depersonalization domain of Maslach Burnout Inventory, 44.7 percent of oncologists were burned out (AP, 45.9 percent; PP, 50.5 percent; P = 0.18). In univariate and multivariate analyses, the primary professional predictor of burnout for both PP and AP oncologists was hours per week devoted to direct patient care. While the majority of oncologists in AP and PP were satisfied with their career (82.5 percent) and specialty (80.4 percent) choices, these measures were lower for those in PP than those in AP (all P < 0.006).

"Those oncologists who devote the greatest amount of their professional time to patient care seem to be at greatest risk for burnout," the authors write.

Explore further: Oncologists report high career satisfaction, yet many suffer symptoms of burnout

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Oncologists report high career satisfaction, yet many suffer symptoms of burnout

June 2, 2013
Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American ...

Survey finds symptoms of burnout common among US physicians

August 20, 2012
A national survey of 7,288 physicians (26.7 percent participation rate) finds that 45.8 percent of physicians reported at least one symptom of burnout, according to a report published Online First by Archives of Internal ...

High rates of burnout and depression among anesthesia residents

June 20, 2013
Residents in anesthesiology training programs have high rates of burnout and depression, reports a survey study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society ...

Oncologists generally refer to specialized palliative care late

October 30, 2012
(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. ...

Administering chemo ups income for non-salaried oncologists

January 2, 2013
(HealthDay)—Non-salaried oncologists report the potential for increased salaries with the administration of chemotherapy or growth factors for lung or colorectal cancer patients, according to a study published online Dec. ...

Most physicians report being satisfied with career choice

September 9, 2013
(HealthDay)—Most physicians report being satisfied with their career choice, although 40 percent would rethink their path given the chance to choose again, according to the 2013 Great American Physician Survey published ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.